Graft hyporeactivity induced by immature donor-derived dendritic cells

被引:18
作者
Hirano, A
Luke, PPW
Specht, SM
Fraser, MO
Takayama, T
Lu, LN
Hoffman, R
Thomson, AW
Jordan, ML [1 ]
机构
[1] Univ Pittsburgh, Med Ctr, Dept Urol, Pittsburgh, PA 15260 USA
[2] Vet Adm Med Ctr, Pittsburgh, PA 15240 USA
[3] Univ Pittsburgh, Med Ctr, Dept Surg, Pittsburgh, PA 15260 USA
[4] Univ Pittsburgh, Med Ctr, Dept Mol Genet & Biochem, Pittsburgh, PA 15260 USA
关键词
immature dendritic cells; anti-donor cytolytic activity; allograft;
D O I
10.1016/S0966-3274(00)00022-8
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Immature dendritic cells (DCs) are deficient in surface co-stimulatory molecules and have been shown to exhibit a 'tolerogenic' potential. We investigated the allostimulatory activity of immature DCs in one-way mixed leukocyte reactions and their capacity to inhibit anti-donor cytolytic activity in the sponge matrix allograft model. Immature DCs (CD80 and CD86 deficient) were derived from bone marrow cells propagated in GM-CSF and TGF-beta1. Mature DCs (CD80(+) and CD86(+)) were derived from bone marrow cells propagated in GM-CSF and IL-4. Either 2 x 10(6) DBA/2J (DBA, H-2(d)) immature DCs or 2 x 10(6) mature DCs were injected intravenously into C57BL/6J (B6, H-2(b)) mice 7 days prior to sponge matrix allograft implantation. On day 12, the sponge was harvested and the graft-infiltrating cells were tested in vitro for cytotoxic T lymphocyte (CTL) activity. Immature dendritic cell (DC) infused significantly and markedly inhibited intra-graft CTL activity compared to mature DCs and syngeneic bone marrow control cells. The administration of immature DCs directly into the sponge allograft failed to induce hyporeactivity. Thus, the only systemic infusion of immature donor DCs was able to recapitulate the donor-specific transfusion effect, and the capacity of donor bone marrow cells to induce donor-specific hyporeactivity in the sponge allograft model. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:161 / 168
页数:8
相关论文
共 37 条
  • [1] ASCHER NL, 1983, J IMMUNOL, V131, P617
  • [2] AUSTYN JM, 1993, ADV EXP MED BIOL, V329, P489
  • [3] Dendritic cells and the control of immunity
    Banchereau, J
    Steinman, RM
    [J]. NATURE, 1998, 392 (6673) : 245 - 252
  • [4] LONG-TERM RESULTS OF A CONTROLLED PROSPECTIVE-STUDY WITH TRANSFUSION OF DONOR-SPECIFIC BONE-MARROW IN 57 CADAVERIC RENAL-ALLOGRAFT RECIPIENTS
    BARBER, WH
    MANKIN, JA
    LASKOW, DA
    DEIERHOI, MH
    JULIAN, BA
    CURTIS, JJ
    DIETHELM, AG
    [J]. TRANSPLANTATION, 1991, 51 (01) : 70 - 75
  • [5] BISHOP DK, 1992, J IMMUNOL, V148, P1049
  • [6] Bonham C A, 1996, Transpl Immunol, V4, P186, DOI 10.1016/S0966-3274(96)80015-3
  • [7] DONOR-SPECIFIC TRANSFUSION AND DONOR BONE-MARROW INFUSION IN RENAL-TRANSPLANTATION TOLERANCE - A REVIEW OF EFFICACY AND MECHANISMS
    BRENNAN, DC
    MOHANAKUMAR, T
    FLYE, MW
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (05) : 701 - 715
  • [8] Derynck R, 1994, CYTOKINE HDB, P319
  • [9] Immunotherapy of NOD mice with bone marrow-derived dendritic cells
    Feili-Hariri, M
    Dong, X
    Alber, SM
    Watkins, SC
    Salter, RD
    Morel, PA
    [J]. DIABETES, 1999, 48 (12) : 2300 - 2308
  • [10] Costimulatory molecule-deficient dendritic cell progenitors (MHC class II+, CD80(dim), CD86(-)) prolong cardiac allograft survival in nonimmunosuppressed recipients
    Fu, FM
    Li, YP
    Qian, SG
    Lu, LN
    Chambers, F
    Starzl, TE
    Fung, JJ
    Thomson, AW
    [J]. TRANSPLANTATION, 1996, 62 (05) : 659 - 665